HNF4A and hepatocellular carcinoma: These data provide a model by which the upregulation of P2-HNF4α is causal for downregulation of BMAL1 expression in human HCC, consistent with findings in exon swap mice expressing P2-HNF4α in normal liver (Fig. 5).